Research Output per year
Fingerprint Dive into the research topics where Lucia Garetto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Fetal Blood
Medicine & Life Sciences
Thrombopoietin
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Intercellular Signaling Peptides and Proteins
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Stem Cells
Medicine & Life Sciences
Hematopoietic Stem Cells
Medicine & Life Sciences
Megakaryocyte Progenitor Cells
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1995 2016
- 705 Citations
- 9 h-Index
- 16 Article
1
Citation
(Scopus)
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: A case report
Fenocchio, E., Depetris, I., Campanella, D., Garetto, L., Carnevale Schianca, F., Galizia, D., Grignani, G., Aglietta, M. & Leone, F., Oct 12 2016, In : BMC Cancer. 16, 1, 793.Research output: Contribution to journal › Article
gemcitabine
Interstitial Lung Diseases
Lung
Pancreatic Neoplasms
Pneumonia
19
Citations
(Scopus)
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
Novello, S., Bruzzi, P., Barone, C., Buosi, R., Masotti, A., Michett, G., Fioretti, M., Barbera, S., Spatafora, M., Garetto, L., Mazzanti, P., Dongiovanni, V., Selvaggi, G., Crinò, L. & Scagliotti, G. V., May 2007, In : Annals of Oncology. 18, 5, p. 903-908 6 p.Research output: Contribution to journal › Article
gemcitabine
Random Allocation
Non-Small Cell Lung Carcinoma
Cisplatin
Survival
The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005
Montemurro, F., Valabrega, G., Garetto, L., Aliberti, S., Grignani, G., Ortega, C., Leone, F., Ponzone, R. & Aglietta, M., Dec 2005, In : Expert Opinion on Pharmacotherapy. 6, 16, p. 2907-2921 15 p.Research output: Contribution to journal › Article
Neoplasms
Translational Medical Research
Medical Oncology
Drug Design
Therapeutics
7
Citations
(Scopus)
A phase II study of α-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia
Rosti, G., Bonifazi, F., Trabacchi, E., de Vivo, A., Bassi, S., Martinelli, G., Testoni, N., Russo, D., Baccarani, M., Peta, A., Iuliano, F., Rotoli, B., Luciano, L., Fanin, R., Tiribelli, M., Boccadoro, M., Ferrero, D., Fioritoni, G., Di Lorenzo, R., Volpe, E. & 40 others, , Mar 1 2003, In : Leukemia. 17, 3, p. 554-559 6 p.Research output: Contribution to journal › Article
Cytosine
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interferons
interferon alfa-2b
Leukemia, Myeloid, Chronic Phase
24
Citations
(Scopus)
The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation
Cignetti, A., Vallario, A., Roato, I., Circosta, P., Strola, G., Scielzo, C., Allione, B., Garetto, L., Caligaris-Cappio, F. & Ghia, P., Jun 1 2003, In : Experimental Hematology. 31, 6, p. 495-503 9 p.Research output: Contribution to journal › Article
Chemokine Receptors
Chemokines
Acute Myeloid Leukemia
CCR2 Receptors
Leukemia, Myelomonocytic, Acute